Evidence map›Paper›PMID 41079825›Full record

ArticleClinical case reports2025

A Rare Case of Choriocarcinoma With Myometrial Invasion Mimicking Invasive Mole: Case Report.

Shaghayegh Vandadi, Afsaneh Tehranian, Nasim Zarifi, Akram Seifollahi, Amirhossein Hajialigol

Abstract read
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shaghayegh VandadiDepartment of Obstetrics and Gynecology, Arash Women's Hospital, School of Medicine Tehran University of Medical Sciences Tehran Iran.
Afsaneh TehranianDepartment of Obstetrics and Gynecology, Arash Women's Hospital, School of Medicine Tehran University of Medical Sciences Tehran Iran.
Nasim ZarifiDepartment of Obstetrics and Gynecology, Arash Women's Hospital, School of Medicine Tehran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0009-0005-1944-5901
Akram SeifollahiDepartment of Obstetrics and Gynecology, Arash Women's Hospital, School of Medicine Tehran University of Medical Sciences Tehran Iran.
Amirhossein HajialigolAlborz Office of Universal Scientific Education and Research Network (USERN), Alborz University of Medical Sciences Karaj Iran.ORCID https://orcid.org/0000-0001-7701-9840

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gestational trophoblastic neoplasia (GTN) comprises a group of rare tumors arising from placental trophoblastic tissue, including choriocarcinoma and invasive mole. We present a rare case of choriocarcinoma with isolated myometrial invasion in a 30-year-old woman with a history of molar pregnancy and term delivery. The clinical presentation mimicked an invasive mole, with elevated β-hCG levels and imaging revealing a vascular myometrial mass. Following a failed dilation and evacuation, and in light of the patient's desire to preserve fertility, conservative surgery via laparotomy was performed. Pathology confirmed choriocarcinoma with myometrial and vascular invasion. Postoperative treatment with actinomycin-D chemotherapy led to remission, and the patient remained disease-free at two-year follow-up. This case emphasizes the importance of histopathological confirmation in GTN diagnosis and illustrates that conservative surgical management, when appropriate, can achieve both oncologic control and fertility preservation.

Indexed as

Beta‐hCGchoriocarcinomafertility preservationgestational trophoblastic neoplasiainvasive molemyometrial invasion

Identifiers

PMID41079825
PMCPMC12507534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.